Compound details
18-O-Methylvibsanin G
| Compound ID | CDAMM02018 |
|---|---|
| Common name | 18-O-Methylvibsanin G | IUPAC name | 2-[2-(3-hydroxy-4-methylpent-4-enyl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate |
| Molecular formula | C26H38O6 |
| Retention time | 4.7 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 447.275 | Theoretical mz | 447.274 |
| Error | 1.84 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.108 |
| Inchi key | CZICNTPMRXWHHG-UOZLJPLINA-N |
|---|---|
| Smiles | O=C(OC=CC1C(C(=O)C(=CCC1(C)CCC(O)C(=C)C)COC)CC(=O)C)C=C(C)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P06241 | FYN | Tyrosine-protein kinase FYN | T17980 | SwissTargetPrediction |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P00797 | REN | Renin | T61622 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P06239 | LCK | Tyrosine-protein kinase LCK | T12499 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| P11940 | PABPC1 | Polyadenylate-binding protein 1 | T58679 | SwissTargetPrediction |
| Q16739 | UGCG | Ceramide glucosyltransferase | T14908 | SwissTargetPrediction |
| P21554 | CNR1 | Cannabinoid receptor 1 (by homology) | T76685 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction |
| P21980 | TGM2 | Protein-glutamine gamma-glutamyltransferase | T05387 | SwissTargetPrediction |
| P07384 | CAPN1 | Calpain 1 | T92517 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| O75469 | NR1I2 | Pregnane X receptor | T82702 | SwissTargetPrediction |
| P07339 | CTSD | Cathepsin D | T67102 | SwissTargetPrediction |
| P17655 | CAPN2 | Calpain 2 | T86837 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| P00519 | ABL1 | Tyrosine-protein kinase ABL | T63505 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P49327 | FASN | Fatty acid synthase | T16514 | SwissTargetPrediction |
| P35270 | SPR | Substance-P receptor | T47094 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P37288 | AVPR1A | Vasopressin V1a receptor (by homology) | T79232 | SwissTargetPrediction |
| P30518 | AVPR2 | Vasopressin V2 receptor (by homology) | T66237 | SwissTargetPrediction |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SwissTargetPrediction |
| P00742 | F10 | Thrombin and coagulation factor X | T84631 | SwissTargetPrediction |
| P51449 | RORC | Nuclear receptor ROR-gamma | T25307 | SwissTargetPrediction |
| Q16850 | CYP51A1 | Cytochrome P450 51 (by homology) | T32972 | SwissTargetPrediction |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SwissTargetPrediction |
| P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | T18477 | SwissTargetPrediction |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction |
| Q15858 | SCN9A | Sodium channel protein type IX alpha subunit | T12119 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P34972 | CNR2 | Cannabinoid receptor 2 | T37693 | SwissTargetPrediction |
| P20142 | PGC | Pepsinogen C (by homology) | T45601 | SwissTargetPrediction |
| P14091 | CTSE | Cathepsin E | T16891 | SwissTargetPrediction |
| P0DJD9 | PGA5 | Pepsin A | T17863 | SwissTargetPrediction |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor | T15439 | SwissTargetPrediction |
| P49336 | CDK8 | Cell division protein kinase 8 | T10822 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P53350 | PLK1 | Serine/threonine-protein kinase PLK1 | T40694 | SwissTargetPrediction |
| P68400 | CSNK2A1 | Casein kinase II alpha | T51565 | SwissTargetPrediction |
| P19784 | CSNK2A2 | Casein kinase II alpha (prime) | T80526 | SwissTargetPrediction |
| P48067 | SLC6A9 | Glycine transporter 1 | T69685 | SwissTargetPrediction |
| P41180 | CASR | Calcium sensing receptor | T92076 | SwissTargetPrediction |
| P56373 | P2RX3 | P2X purinoceptor 3 | T17140 | SwissTargetPrediction |
| Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | T77537 | SwissTargetPrediction |
| Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | T23787 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| P28074 | PSMB5 | Proteasome Macropain subunit MB1 | T49031 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| O14649 | KCNK3 | Potassium channel subfamily K member 3 | T15795 | SwissTargetPrediction |
| P53671 | LIMK2 | LIM domain kinase 2 | T09133 | SwissTargetPrediction |
| P35557 | GCK | Hexokinase type IV | T87166 | SwissTargetPrediction |
| P43490 | NAMPT | Nicotinamide phosphoribosyltransferase | T54582 | SwissTargetPrediction |
| P25106 | ACKR3 | C-X-C chemokine receptor type 7 | T10491 | SwissTargetPrediction |
| O15151 | MDM4 | Protein Mdm4 | T36741 | SwissTargetPrediction |
| P00746 | CFD | Complement factor D | T66383 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| Q12866 | MERTK | Proto-oncogene tyrosine-protein kinase MER | T55781 | SwissTargetPrediction |
| Q06418 | TYRO3 | Tyrosine-protein kinase receptor TYRO3 | T94880 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| Q08828 | ADCY1 | Brain adenylate cyclase 1 | T63609 | SwissTargetPrediction |
| P30530 | AXL | Tyrosine-protein kinase receptor UFO | T82383 | SwissTargetPrediction |
| P49682 | CXCR3 | C-X-C chemokine receptor type 3 | T25315 | SwissTargetPrediction |
| Q9Y345 | SLC6A5 | Glycine transporter 2 | T58937 | SwissTargetPrediction |
| Q99884 | SLC6A7 | Sodium-dependent proline transporter | T54982 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T17980 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06241 | FYN |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T61622 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P00797 | REN |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T12499 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06239 | LCK |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T58679 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11940 | PABPC1 |
| T14908 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | Q16739 | UGCG |
| T14908 | DI0257 | Metabolic disorder | [ICD-11: 5C50-5D2Z] | Q16739 | UGCG |
| T76685 | DI0031 | Anorexia nervosa | [ICD-11: 6B80] | P21554 | CNR1 |
| T76685 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P21554 | CNR1 |
| T76685 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P21554 | CNR1 |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T05387 | DI0092 | Coeliac disease | [ICD-11: DA95] | P21980 | TGM2 |
| T05387 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P21980 | TGM2 |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T67102 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07339 | CTSD |
| T86837 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P17655 | CAPN2 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T63505 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00519 | ABL1 |
| T63505 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00519 | ABL1 |
| T63505 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P00519 | ABL1 |
| T63505 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00519 | ABL1 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T16514 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P49327 | FASN |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T79232 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37288 | AVPR1A |
| T79232 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P37288 | AVPR1A |
| T79232 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37288 | AVPR1A |
| T79232 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P37288 | AVPR1A |
| T79232 | DI0236 | Localisation | [ICD-11: N.A.] | P37288 | AVPR1A |
| T66237 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30518 | AVPR2 |
| T66237 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30518 | AVPR2 |
| T66237 | DI0131 | Enuresis | [ICD-11: 6C00] | P30518 | AVPR2 |
| T66237 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P30518 | AVPR2 |
| T66237 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30518 | AVPR2 |
| T66237 | DI0338 | Polyuria | [ICD-11: MF55] | P30518 | AVPR2 |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T84631 | DI0053 | Blood-forming organ disease | [ICD-11: 3C0Z] | P00742 | F10 |
| T84631 | DI0080 | Christmas disease | [ICD-11: 3B11] | P00742 | F10 |
| T84631 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00742 | F10 |
| T84631 | DI0103 | Coronary thrombosis | [ICD-11: BA43] | P00742 | F10 |
| T84631 | DI0114 | Deep vein thrombosis | [ICD-11: BD71] | P00742 | F10 |
| T84631 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P00742 | F10 |
| T84631 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00742 | F10 |
| T84631 | DI0433 | Venous thromboembolism | [ICD-11: BD72] | P00742 | F10 |
| T25307 | DI0042 | Autoimmune disease | [ICD-11: 4A40-4A45] | P51449 | RORC |
| T25307 | DI0107 | Crohn disease | [ICD-11: DD70] | P51449 | RORC |
| T25307 | DI0238 | Lung cancer | [ICD-11: 2C25] | P51449 | RORC |
| T25307 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P51449 | RORC |
| T25307 | DI0351 | Psoriasis | [ICD-11: EA90] | P51449 | RORC |
| T25307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P51449 | RORC |
| T32972 | DI0209 | Infectious meningitis | [ICD-11: 1D01] | Q16850 | CYP51A1 |
| T32972 | DI0289 | Nail/perionychium infection | [ICD-11: EE12] | Q16850 | CYP51A1 |
| T32972 | DI0316 | Onchocerciasis | [ICD-11: 1F6A] | Q16850 | CYP51A1 |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T18477 | DI0015 | Acute upper respiratory infection | [ICD-11: CA07] | P07900 | HSP90AA1 |
| T18477 | DI0037 | Asthma | [ICD-11: CA23] | P07900 | HSP90AA1 |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T12119 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q15858 | SCN9A |
| T12119 | DI0087 | Chronic pain | [ICD-11: MG30] | Q15858 | SCN9A |
| T12119 | DI0140 | Extremities vasodilatation | [ICD-11: EG00] | Q15858 | SCN9A |
| T12119 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q15858 | SCN9A |
| T12119 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q15858 | SCN9A |
| T12119 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q15858 | SCN9A |
| T12119 | DI0358 | Radiculopathy | [ICD-11: 8B93] | Q15858 | SCN9A |
| T12119 | DI0415 | Trigeminal nerve disorder | [ICD-11: 8B82] | Q15858 | SCN9A |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T37693 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34972 | CNR2 |
| T37693 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P34972 | CNR2 |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T15439 | DI0431 | Vasculitis | [ICD-11: 4A44] | P21730 | C5AR1 |
| T10822 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P49336 | CDK8 |
| T10822 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P49336 | CDK8 |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T40694 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P53350 | PLK1 |
| T40694 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P53350 | PLK1 |
| T40694 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P53350 | PLK1 |
| T51565 | DI0104 | Coronavirus infection | [ICD-11: 1D92] | P68400 | CSNK2A1 |
| T51565 | DI0235 | Liver cancer | [ICD-11: 2C12] | P68400 | CSNK2A1 |
| T51565 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P68400 | CSNK2A1 |
| T69685 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P48067 | SLC6A9 |
| T92076 | DI0189 | Hyper-parathyroidism | [ICD-11: 5A51] | P41180 | CASR |
| T17140 | DI0105 | Cough | [ICD-11: MD12] | P56373 | P2RX3 |
| T23787 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16875 | PFKFB3 |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T15795 | DI0309 | Obstructive sleep apnoea | [ICD-11: 7A41] | O14649 | KCNK3 |
| T87166 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P35557 | GCK |
| T87166 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P35557 | GCK |
| T87166 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35557 | GCK |
| T87166 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P35557 | GCK |
| T54582 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P43490 | NAMPT |
| T54582 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P43490 | NAMPT |
| T54582 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P43490 | NAMPT |
| T10491 | DI0037 | Asthma | [ICD-11: CA23] | P25106 | ACKR3 |
| T10491 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25106 | ACKR3 |
| T36741 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O15151 | MDM4 |
| T36741 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O15151 | MDM4 |
| T36741 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O15151 | MDM4 |
| T36741 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15151 | MDM4 |
| T66383 | DI0170 | Haemolytic anemia | [ICD-11: 3A20-3A2Z] | P00746 | CFD |
| T66383 | DI0365 | Retinopathy | [ICD-11: 9B71] | P00746 | CFD |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T55781 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q12866 | MERTK |
| T55781 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q12866 | MERTK |
| T55781 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | Q12866 | MERTK |
| T55781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q12866 | MERTK |
| T94880 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06418 | TYRO3 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T63609 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q08828 | ADCY1 |
| T82383 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P30530 | AXL |
| T25315 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P49682 | CXCR3 |
| T25315 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P49682 | CXCR3 |
| T25315 | DI0351 | Psoriasis | [ICD-11: EA90] | P49682 | CXCR3 |
| T25315 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49682 | CXCR3 |